Florence Magrangeas

Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

Journal: Blood cancer journal

Published: January 07, 2026

Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Author Correction: Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Journal: Nature cancer

Published: September 08, 2023

Exploring the impact of dexamethasone on gene regulation in myeloma cells.

Exploring the impact of dexamethasone on gene regulation in myeloma cells.

Journal: Life science alliance

Published: June 01, 2023

Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation.

Journal: Nature cancer

Published: May 23, 2023

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.

Journal: Blood cancer journal

Published: September 07, 2022

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.

Journal: Blood

Published: May 27, 2022

Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study.

Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 09, 2021

The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability.

The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability.

Journal: Genome medicine

Published: August 17, 2020

Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group.

Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 21, 2020

DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.

DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myeloma.

Journal: Clinical epigenetics

Published: June 23, 2020

Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.

Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.

Journal: Hematological oncology

Published: March 11, 2020

Deciphering the chronology of copy number alterations in Multiple Myeloma.

Deciphering the chronology of copy number alterations in Multiple Myeloma.

Journal: Blood cancer journal

Published: January 22, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026